113 related articles for article (PubMed ID: 7726955)
1. Serum screening for Down's syndrome. Private patients may receive less counselling.
Boyd PA
BMJ; 1994 Nov; 309(6965):1372. PubMed ID: 7726955
[No Abstract] [Full Text] [Related]
2. Serum screening for Down's syndrome. Counselling should emphasise possible outcomes of screening.
Allaby M
BMJ; 1994 Nov; 309(6965):1373. PubMed ID: 7866103
[No Abstract] [Full Text] [Related]
3. Antenatal screening for neural tube defects and Down's syndrome--the importance of pretest counselling.
Seman E
Med J Aust; 1994 May; 160(10):658-60. PubMed ID: 8177121
[No Abstract] [Full Text] [Related]
4. Serum screening for Down's syndrome. Keeping the concept of risk simple.
Barrow M; Smith JF; Stewart C
BMJ; 1994 Nov; 309(6965):1373. PubMed ID: 7866104
[No Abstract] [Full Text] [Related]
5. Serum screening for Down's syndrome. Private screening is problematic.
Reynolds TM
BMJ; 1993 Aug; 307(6902):501. PubMed ID: 8400946
[No Abstract] [Full Text] [Related]
6. Counselling needed after screening for Down's syndrome.
Dennis J; Sawtell M; Rutter S
BMJ; 1993 Oct; 307(6910):1005. PubMed ID: 8241886
[No Abstract] [Full Text] [Related]
7. Serum screening for Down's syndrome. National policy would ensure consistency.
Reynolds T; John R
BMJ; 1994 Nov; 309(6965):1372-3. PubMed ID: 7866102
[No Abstract] [Full Text] [Related]
8. Psychological consequences of screening for Down's syndrome.
Marteau TM
BMJ; 1993 Jul; 307(6897):146-7. PubMed ID: 8343740
[No Abstract] [Full Text] [Related]
9. The value of screening for Down's syndrome in a socioeconomically deprived area with a high ethnic population.
Esen U; Olajide F
Br J Obstet Gynaecol; 1999 Jan; 106(1):87. PubMed ID: 10426267
[No Abstract] [Full Text] [Related]
10. Using decision analysis to compare policies for antenatal screening for Down's syndrome.
Fletcher J; Hicks NR; Kay JD; Boyd PA
BMJ; 1995 Aug; 311(7001):351-6. PubMed ID: 7640539
[TBL] [Abstract][Full Text] [Related]
11. Prenatal screening for Down's syndrome with use of maternal serum markers.
Haddow JE; Palomaki GE; Knight GJ; Williams J; Pulkkinen A; Canick JA; Saller DN; Bowers GB
N Engl J Med; 1992 Aug; 327(9):588-93. PubMed ID: 1379344
[TBL] [Abstract][Full Text] [Related]
12. Informed consent to undergo serum screening for Down's syndrome: the gap between policy and practice.
Smith DK; Shaw RW; Marteau TM
BMJ; 1994 Sep; 309(6957):776. PubMed ID: 7950565
[No Abstract] [Full Text] [Related]
13. Serum screening for Down's syndrome: experiences of obstetricians in England and Wales.
Green JM
BMJ; 1994 Sep; 309(6957):769-72. PubMed ID: 7950560
[TBL] [Abstract][Full Text] [Related]
14. Prenatal screening for Down's syndrome.
BMJ; 1991 Jul; 303(6793):54-6. PubMed ID: 1830503
[No Abstract] [Full Text] [Related]
15. Prenatal screening for Down's syndrome.
BMJ; 1991 Aug; 303(6800):468-9. PubMed ID: 1833008
[No Abstract] [Full Text] [Related]
16. Prenatal screening for Down's syndrome.
BMJ; 1991 Sep; 303(6804):715-6. PubMed ID: 1833015
[No Abstract] [Full Text] [Related]
17. Antenatal screening for Down's syndrome.
Wishart JG
BMJ; 1992 Sep; 305(6856):770; author reply 771. PubMed ID: 1422343
[No Abstract] [Full Text] [Related]
18. Screening for Down's syndrome.
Keatinge RM; Williams ES
BMJ; 1991 Oct; 303(6809):1063. PubMed ID: 1835415
[No Abstract] [Full Text] [Related]
19. Antenatal screening for Down's syndrome.
Topping J; McCormack MJ; Howells RT
BMJ; 1992 Sep; 305(6856):771. PubMed ID: 1422344
[No Abstract] [Full Text] [Related]
20. Maternal serum screening for neural tube defects and Down's syndrome.
Robertson EF
Med J Aust; 1991 Sep; 155(5):349. PubMed ID: 1832734
[No Abstract] [Full Text] [Related]
[Next] [New Search]
